What Happened?
Research Triangle Park, NC-based Locus-Biosciences Appointed Paul Garofolo as Chief Executive Officer
About the Company
Locus Biosciences` novel approach to precision antimicrobials works by taking advantage of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating a small strand of RNA called a CRISPR RNA, which matches a DNA sequence specific to a given invader. If the CRISPR RNA is matched to a complementary DNA sequence, the Cas proteins will cleave the invading DNA.
About the Person
Paul Garofolo is Chief Executive Officer at Locus Biosciences. Previously, Paul held various senior HR leadership roles in the industry.
Info Source
News
Short Profile